A blue box stating: Australia's most comprehensive microbiome testing.

Our vision is to improve lives through a deeper understanding of the gut microbiome

Microba is an Australian company working to create a community of greater health. Built on leading scientific research, Microba has established itself as a world leader in the analysis of the gut microbiome. With a growing body of global research indicating that the gut microbiome plays a central role in health and disease, Microba is a strong contributing force in the development of new pathology services, therapeutics and diagnostics based on the microbiome.

The research that Microba is based upon was developed by Professor Gene Tyson and Professor Phillip Hugenholtz over the past 20 years and has been made possible from the advancement in computing power over the past decade.

They wanted to make research-quality microbiome analysis available more broadly so everyone could have the opportunity to gain deep insight into their gut microbiome and improve their health and wellbeing.

Both founders are actively involved, helping guide the direction of the company and ensure operations meet the highest standards of evidence-based science.

Our laboratories in Brisbane have the latest metagenomic testing equipment, comprehensive quality assurance protocols and a skilled team of scientists ensuring each test is accurate.

Be part of the health revolution.

A waist/head portrait of Phil Hugenholtz

Professor Philip Hugenholtz

Role: Co-Founder

Professor Phil Hugenholtz is Microba’s co-founder, a fellow of the Australian Academy of Science and a world-leading expert in microbiome analysis.

Throughout his career as a microbiologist, he has published over one hundred papers in high-impact journals in the field of microbiology and genomics. He has been involved in pioneering many of the methods used in microbiome analysis, including whole genome metagenomic DNA sequencing, and discovered and characterised a number of previously unknown bacterial species. In his role at Microba, he continues to drive the discovery of new insights into the human gut microbiome.

Professor Hugenholtz is also Director of the Australian Centre for Ecogenomics (ACE), Australia’s leading centre for genomic research.


A torso/face portrait of Professor Gene Tyson

Professor Gene Tyson

Role: Co-Founder

Professor Gene Tyson is Microba’s co-founder and a world-leading expert in microbiome analysis.

As a microbial ecologist, Professor Tyson was the first person to publish the use of metagenomic sequencing for assessing microbial communities. This paper highlighted the potential of metagenomics to provide a clearer picture of microbial communities. In his role at Microba, he continues to explore the use of these approaches he helped pioneer to discover even more about the human gut microbiome.

Professor Tyson is also the head of microbiome research at the Queensland University of Technology and an Honorary Professor with the School of Chemistry and Molecular Biosciences at The University of Queensland.


Be part of Australian advances and worldwide research

Our laboratory and researchers are part of the exciting ongoing microbiome research here and overseas. This is one of the new frontiers of medicine, revealing important connections about how microorganisms are affecting our health. Human microbiome research has exciting potential to diagnose disease and discover new therapies. Your data can be part of it too if you give us permission to use your dietary, lifestyle and health information anonymously.

Your Contribution

You have the opportunity to contribute to important research about how the human gut microbiome influences health by participating in a further questionnaire about your health and wellbeing that can be matched to your microbiome analysis.

Ethical Compass

We conduct our business in a socially responsible, ethical and scientifically rigorous manner. We respect the law and regulatory requirements. We aim to improve individual wellbeing and benefit the communities where we work.

As featured in recent media

“This is one of the new frontiers of medicine, revealing important connections about how microorganisms are affecting our health.”

– Prof Gene Tyson

Prof Ian Frazer AC

Non-Executive Director

Prof Phil Hugenholtz

Co-founder, Chair of Scientific Advisory Board

Prof Gene Tyson

Co-founder, Non-Executive Director

Dr Luke Reid


Dr Alena Pribyl

Senior Scientist & Research Officer

Dr David Wood

Head of Bioinformatics Operations

Dr Kaylyn Tousignant

Scientific Writer

Dr Nicola Angel

Head of Laboratory Operations

Dr Ken McGrath

Clinical Solutions Manager

Hayley Parcell

Head of Insight™

Dr Paula Smith-Brown

Clinical Science Lead

Dr Brad Leech

Lead Clinical Educator

Krystyna Sullivan

Senior Clinical Application Specialist

Christine Stewart

Clinical Application Specialist

Christal Jux

Clinical Application Specialist

Alana Krahe

Marketing Manager